A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer

Breast J. 2020 Dec;26(12):2420-2423. doi: 10.1111/tbj.14108. Epub 2020 Dec 5.
No abstract available

Keywords: adoptive immunotherapy; bevacizumab; breast cancer; αβ T-cell.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Immunotherapy, Adoptive
  • Paclitaxel*
  • T-Lymphocytes

Substances

  • Bevacizumab
  • Paclitaxel